187 related articles for article (PubMed ID: 33433939)
1. Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.
O'Brien KM; Tworoger SS; Harris HR; Trabert B; Weinberg CR; Fortner RT; D'Aloisio AA; Kaunitz AM; Wentzensen N; Sandler DP
Int J Cancer; 2021 Jun; 148(11):2692-2701. PubMed ID: 33433939
[TBL] [Abstract][Full Text] [Related]
2. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
[TBL] [Abstract][Full Text] [Related]
3. Perineal powder use and risk of ovarian cancer.
Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
[TBL] [Abstract][Full Text] [Related]
4. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
Wentzensen N; O'Brien KM
Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
[TBL] [Abstract][Full Text] [Related]
5. Perineal Talc Use, Douching, and the Risk of Uterine Cancer.
O'Brien KM; D'Aloisio AA; Shi M; Murphy JD; Sandler DP; Weinberg CR
Epidemiology; 2019 Nov; 30(6):845-852. PubMed ID: 31584892
[TBL] [Abstract][Full Text] [Related]
6. Perineal use of talcum powder and endometrial cancer risk.
Karageorgi S; Gates MA; Hankinson SE; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1269-75. PubMed ID: 20406962
[TBL] [Abstract][Full Text] [Related]
7. The association between douching, genital talc use, and the risk of prevalent and incident cervical cancer.
O'Brien KM; Weinberg CR; D'Aloisio AA; Moore KR; Sandler DP
Sci Rep; 2021 Jul; 11(1):14836. PubMed ID: 34290340
[TBL] [Abstract][Full Text] [Related]
8. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Terry KL; Karageorgi S; Shvetsov YB; Merritt MA; Lurie G; Thompson PJ; Carney ME; Weber RP; Akushevich L; Lo-Ciganic WH; Cushing-Haugen K; Sieh W; Moysich K; Doherty JA; Nagle CM; Berchuck A; Pearce CL; Pike M; Ness RB; Webb PM; ; ; Rossing MA; Schildkraut J; Risch H; Goodman MT;
Cancer Prev Res (Phila); 2013 Aug; 6(8):811-21. PubMed ID: 23761272
[TBL] [Abstract][Full Text] [Related]
9. Perineal powder use and risk of endometrial cancer in postmenopausal women.
Crawford L; Reeves KW; Luisi N; Balasubramanian R; Sturgeon SR
Cancer Causes Control; 2012 Oct; 23(10):1673-80. PubMed ID: 22875750
[TBL] [Abstract][Full Text] [Related]
10. Association of genital talc and douche use in early adolescence or adulthood with uterine fibroids diagnoses.
Ogunsina K; Sandler DP; Murphy JD; Harmon QE; D'Aloisio AA; Baird DD; O'Brien KM
Am J Obstet Gynecol; 2023 Dec; 229(6):665.e1-665.e10. PubMed ID: 37598998
[TBL] [Abstract][Full Text] [Related]
11. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study.
Bertrand KA; Delp L; Coogan PF; Cozier YC; Lenzy YM; Rosenberg L; Palmer JR
Environ Res; 2023 Dec; 239(Pt 1):117228. PubMed ID: 37821068
[TBL] [Abstract][Full Text] [Related]
12. Douching, Talc Use, and Risk of Ovarian Cancer.
Gonzalez NL; O'Brien KM; D'Aloisio AA; Sandler DP; Weinberg CR
Epidemiology; 2016 Nov; 27(6):797-802. PubMed ID: 27327020
[TBL] [Abstract][Full Text] [Related]
13. Genital powder exposure and the risk of epithelial ovarian cancer.
Rosenblatt KA; Weiss NS; Cushing-Haugen KL; Wicklund KG; Rossing MA
Cancer Causes Control; 2011 May; 22(5):737-42. PubMed ID: 21516319
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of talc use and ovarian cancer.
Gertig DM; Hunter DJ; Cramer DW; Colditz GA; Speizer FE; Willett WC; Hankinson SE
J Natl Cancer Inst; 2000 Feb; 92(3):249-52. PubMed ID: 10655442
[TBL] [Abstract][Full Text] [Related]
15. Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.
Davis CP; Bandera EV; Bethea TN; Camacho F; Joslin CE; Wu AH; Beeghly-Fadiel A; Moorman PG; Myers ER; Ochs-Balcom HM; Peres LC; Rosenow WT; Setiawan VW; Rosenberg L; Schildkraut JM; Harris HR
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1660-1668. PubMed ID: 34155063
[TBL] [Abstract][Full Text] [Related]
16. Body composition and risk of major gynecologic malignancies: Results from the UK Biobank prospective cohort.
Yun P; Xia B; Tian XH; Gong T; Liu AR; Yuan JQ; Li FP
Cancer Med; 2021 Jul; 10(13):4522-4531. PubMed ID: 34114748
[TBL] [Abstract][Full Text] [Related]
17. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
[TBL] [Abstract][Full Text] [Related]
18. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
19. Use of talcum powder and endometrial cancer risk.
Neill AS; Nagle CM; Spurdle AB; Webb PM
Cancer Causes Control; 2012 Mar; 23(3):513-9. PubMed ID: 22245995
[TBL] [Abstract][Full Text] [Related]
20. Genital talc exposure and risk of ovarian cancer.
Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
